Skip to main content

UPDATED REPORT: Texas Mifepristone Abortion Case Threatens Entire Drug Approval Process

By April 11, 2023No Comments

Read the Report Here.

Washington, DC — Today, Protect Our Care is releasing an updated report detailing the disastrous implications of the medical abortion lawsuit in Texas aiming to ban the abortion medication mifepristone. A decision to ban mifepristone would threaten millions of women’s access to safe and legal abortions and open the door for the politically-motivated destruction of the entire drug approval process.

Last week, Judge Matthew Kacsmaryk issued a ruling to pull mifepristone from the market. Mifepristone is a safe and effective medication that is essential to abortion access across the nation. On Monday, legal and public health advocates joined Protect Our Care to discuss how the ruling has wider implications for the health care system and sets a precedent for any judge to be able to overrule the evidence-based and scientific FDA medication approval process. Watch the full event here.  

Protect Our Care Founder Leslie Dach issued the following statement: 

“Judge Kacysmaryk’s ruling threatens to throw the entire U.S. drug approval process into chaos,” said Protect Our Care Chair Leslie Dach. “It not only puts at risk the use of mifepristone for safe and legal abortions, but it opens the door for the politically-motivated removal of other safe and effective drugs from the market. If the ruling stands, millions of patients will suffer.”